Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
02/26/2003 | EP0941221B1 Substituted dihydrobenzofurans as pde inhibitors |
02/26/2003 | EP0927186B1 Method for producing n-phosphonomethylglycine and its salts |
02/26/2003 | CN1398865A Planar chiral [2,2]-p-cyclo-aralkyl oxazolinyl phosphine ligand and its synthesis and use |
02/26/2003 | CN1398864A Phosphonate ester nucleotide compound |
02/26/2003 | CN1102142C Novel N-acyl sulphonamides, novel mixtures of herbicides and antidotes and their use |
02/25/2003 | US6525215 HIV protease inhibitors |
02/25/2003 | US6525210 Binaphthyl phospholanes, chelating phosphines and ferrocene complexes thereof |
02/25/2003 | US6525143 Dendritic macromolecules for metal-ligand catalyzed processes |
02/25/2003 | US6525041 Low molecular weight mimics of superoxide dismutase; inflammatory disorders, ischemic/reperfusion injury, stroke, atherosclerosis, and all other conditions of oxidant- induced tissue damage or injury |
02/25/2003 | US6524967 Method for incorporating nitrogen into a dielectric layer using a special precursor |
02/25/2003 | CA2123081C Enzymatic preparation of n-(phosphonomethyl) glycine |
02/20/2003 | WO2003014134A1 Precursors for metalorganic chemical vapour deposition |
02/20/2003 | WO2003014133A1 Isoxazoline derivatives as p, n ligands |
02/20/2003 | WO2003014132A1 Method of obtaining cis-1-propenylphosphonate of diterbutyl |
02/20/2003 | WO2003014130A1 High boiling inhibitors for distillable, polymerizable monomers |
02/20/2003 | WO2003013573A1 Polypeptide conjugates with extended circulating half-lives |
02/20/2003 | WO2003013542A1 Asymmetric synthesis of kavalactones |
02/20/2003 | WO2003013502A1 Compounds which mimic the chemical and biological properties of discodermolide |
02/20/2003 | WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
02/20/2003 | WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses |
02/20/2003 | US20030036667 Heating aromatic compound substituted with halogen that is exchangeable for fluorine with fluoride and compound such as Diethylaminobis(tetramethylguanidino)sulfonium bromide to produce fluorinated aromatics |
02/20/2003 | US20030036537 Derivatives of 1-hydroxymethylene-1,1-bisphosphonic acid, useful in the treatment of cancerous tumors. |
02/20/2003 | US20030036536 Substituted benzylthioacetic acids and esters |
02/20/2003 | US20030036534 Naaladase inhibitors for treating retinal disorders and glaucoma |
02/20/2003 | US20030036533 Used in infections by viruses, bacteria, fungi, and parasites |
02/20/2003 | US20030036474 Catalysts with a donor-acceptor interaction |
02/20/2003 | CA2456720A1 Asymmetric synthesis of kavalactones |
02/20/2003 | CA2456553A1 Compounds which mimic the chemical and biological properties of discodermolide |
02/19/2003 | EP1284270A1 Vanadium-Imido-Phosphoraniminato complexes for olefin polymerisation |
02/19/2003 | EP1284269A2 Vanadium imidoaryl complexes for olefin polymerisation |
02/19/2003 | EP1283841A2 Reaction systems for making n-(phosphonomethyl)glycine compounds |
02/19/2003 | EP1283835A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
02/19/2003 | EP1131327B1 Prostaglandin conjugates for treating or preventing bone diseases |
02/19/2003 | EP1115729B1 Phosphonic acid derivatives as inhibitors of ptp-1b |
02/19/2003 | EP1000072B1 Process for the preparation of [2-((8,9)- dioxo-2,6-diazabicyclo [5.2.0]-non-1(7)-en-2-yl)-ethyl] phosphonic acid |
02/19/2003 | EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors |
02/19/2003 | EP0777485B1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
02/19/2003 | CN1398252A Dehydroamino acids compounds |
02/19/2003 | CN1398247A Colchinol derivatives as vascular damaging agents |
02/19/2003 | CN1398200A Phosphor, arsenic and antimony compounds based upon diaryl-anellated bicyclo 2.2.N8cexcl; parent substances and catalysts contg. same |
02/19/2003 | CN1101822C Molecular complex compounds as photoinitiators |
02/18/2003 | US6521795 Minimizing formation of enantiomer with use of catalyst comprising transition metals with chiral ligands |
02/18/2003 | US6521793 Aromatic secondary amines; polymerization catalysts |
02/18/2003 | US6521778 Hydrocyanation of 1,3-butadiene to form adiponitrile |
02/18/2003 | US6521776 Immunological adjuvant compounds compositions and methods of use thereof |
02/18/2003 | US6521769 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions |
02/18/2003 | US6521662 Ceramide-like compounds having antioxidant property and a method for preparation thereof, and a cosmetic composition containing the same |
02/18/2003 | US6521650 Amines as pharmaceutical agents |
02/18/2003 | US6521612 Antibiotic compounds |
02/18/2003 | US6521606 Matrix metalloproteinase inhibitors |
02/18/2003 | US6521605 Amidophosphate derivatives |
02/18/2003 | US6521432 Methods for enhancing the rate of modification of metastable bonds |
02/18/2003 | CA2264508C Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
02/18/2003 | CA2079289C Cardioprotective tocopherol analogs |
02/16/2003 | CA2398244A1 Vanadium-imidoaryl complexes for the polymerization of olefins |
02/16/2003 | CA2397902A1 Vanadium-imido-phosphoraneiminato complexes for the polmerization of olefins |
02/13/2003 | WO2003012900A1 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
02/13/2003 | WO2003011879A1 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
02/13/2003 | WO2003011875A1 Novel transition-metal complexes and use thereof in transition-metal catalysed reactions |
02/13/2003 | WO2003011874A1 Compounds for use as surfactants |
02/13/2003 | WO2003011873A2 Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
02/13/2003 | WO2003011223A2 Immunomodulatory compounds and methods of use thereof |
02/13/2003 | WO2003011221A2 PREPARATION AND USE OF α-KETO PHOSPHONATES |
02/13/2003 | WO2003002581B1 Process for the production of pentaerythritol phosphate alcohol |
02/13/2003 | WO2002076995A3 2-amino-propanol derivatives |
02/13/2003 | WO2002072591A3 Resveratrol-phospholipids complexes |
02/13/2003 | WO2002062156A3 Methods for treating organic acid-treated phosphatides |
02/13/2003 | WO2002046249A3 Methods of copolymerizing ethylene and isobutylene and polymers made thereby |
02/13/2003 | US20030032808 Tri-and bidentate amido ligands prepared by palladium0 coupling and metallation threreof to form metal-amido catalysts |
02/13/2003 | US20030032647 Aromatic nitrogen-containing 6-membered cyclic compounds |
02/13/2003 | US20030032565 Pro-fragrance linear acetals and ketals |
02/13/2003 | US20030032080 Novel potentially fluorogenic compounds and plating media containing same |
02/13/2003 | US20030031873 Laminates for printed wiring boards |
02/13/2003 | CA2493888A1 Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
02/13/2003 | CA2455347A1 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
02/12/2003 | EP1282699A2 Splice-region antisense composition and method |
02/12/2003 | EP1282639A2 Polyamide nucleic acid derivatives, agents and methods for producing the same |
02/12/2003 | EP1282630A1 Hydroxylamine esters as polymerization initiators |
02/12/2003 | EP1282629A1 Bidentate ligands useful in catalyst sytems |
02/12/2003 | EP1282628A2 N-(2-pyrimidinyl)(thio)phosphoric triamides, method for producing the same, and the use thereof as agents for regulating or inhibiting enzymatic urea hydrolysis |
02/12/2003 | EP1282596A1 Preparation of iminodiacetic acid compounds from monoethanolamine substrates |
02/12/2003 | EP1150942A4 Improved compounds for protein binding |
02/12/2003 | EP1133501B1 Calixarene derivatives |
02/12/2003 | EP1133499B1 Complex compound of an element of sub-group iv or v |
02/12/2003 | EP1115400A4 Benzothiazole dioxetanes |
02/12/2003 | EP0863906B1 Heterocyclic dioxethane substrates, process for their preparation and their use |
02/12/2003 | EP0730459B1 The use of an ester of inositoltrisphosphate for the preparing of medicaments |
02/12/2003 | CN1397148A Luminescent element material and luminescent element comprising the same |
02/12/2003 | CN1396926A Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
02/12/2003 | CN1396925A Process for making geminal disphosphonates |
02/12/2003 | CN1396924A Salt of melamine condensation product and phosphorus-containing acid |
02/12/2003 | CN1396170A Crystal form of Pifuadefuwei |
02/12/2003 | CN1396169A Preparing process and usage of thiophosphate |
02/12/2003 | CN1101399C Phosphorus-containing fluoromonomers |
02/12/2003 | CN1101397C Preparation of beta-methyl carbepenem intermediate |
02/11/2003 | US6518325 Halogen-free, water-blown, flame-retardant rigid polyurethane foam and a process for its production |
02/11/2003 | US6518311 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |